Canada keeps end-September COVID vaccination target despite Pfizer delay
Reuters
Published Jan 15, 2021 10:22
Updated Jan 15, 2021 16:06
By Steve Scherer
OTTAWA (Reuters) - Pfizer (NYSE:PFE)'s reduction of its COVID-19 vaccine shipments will not delay Canada's goal of getting most people inoculated by the end of September, the country's procurement minister said on Friday as the country battled a second surge in infections.
"This is a temporary delay and we remain on track to have enough approved vaccines for everyone who wishes to get vaccinated by the end of September 2021," Procurement Minister Anita Anand said.
Pfizer said it would slow production in late January and early February due to changes to manufacturing processes aimed at boosting production, but would provide a "significant increase" in doses in late February and March.
Canada's Major-General Dany Fortin, who is in charge of coordinating the country's vaccine rollout, told reporters Canada will receive about half the Pfizer/BioNTech vaccine over the next four weeks than had been previously expected.
However, Pfizer/BioNTech will "offset" the shortfall and still deliver - as had been planned - some 4 million by the end of March, he said.
"I understand the disappointment. I share the disappointment," Fortin said, echoing the frustration expressed by many Canadians about the slow pace of inoculations, including Prime Minister Justin Trudeau earlier this month.
Canada is struggling to contain a second wave of the novel coronavirus. On Friday, the health ministry said there could be a spike of more than 100,000 new cases in just the next nine days. That means almost 12,000 new cases per day, compared with the 7,565 new cases reported on Thursday.
The spike in cases is being driven mainly by the populous provinces of Ontario and Quebec, health officials said, both of which have imposed health restrictions in recent weeks to try to slow the spread.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.